Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors.

Lécolle K, Bégard S, Caillierez R, Demeyer D, Grellier E, Loyens A, Csaba Z, Beauvillain JC, D'Halluin JC, Baroncini M, Lejeune JP, Sharif A, Prévot V, Dournaud P, Buée L, Colin M.

Gene Ther. 2013 Mar;20(3):283-97. doi: 10.1038/gt.2012.39. Epub 2012 May 17.

PMID:
22592599
2.

A fiber-modified adenoviral vector interacts with immunoevasion molecules of the B7 family at the surface of murine leukemia cells derived from dormant tumors.

Grellier E, Lécolle K, Rogée S, Couturier C, D'Halluin JC, Hong SS, Fender P, Boulanger P, Quesnel B, Colin M.

Mol Cancer. 2011 Aug 31;10:105. doi: 10.1186/1476-4598-10-105.

3.

Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response.

Rogée S, Grellier E, Bernard C, Jouy N, Loyens A, Beauvillain JC, Fender P, Corjon S, Hong SS, Boulanger P, Quesnel B, D'Halluin JC, Colin M.

Gene Ther. 2010 Jul;17(7):880-91. doi: 10.1038/gt.2010.37. Epub 2010 Apr 15.

PMID:
20393506
4.

Non-heparan sulfate GAG-dependent infection of cells using an adenoviral vector with a chimeric fiber conserving its KKTK motif.

Rogée S, Grellier E, Bernard C, Colin M, D'Halluin JC.

Virology. 2008 Oct 10;380(1):60-8. doi: 10.1016/j.virol.2008.07.019. Epub 2008 Aug 22.

5.

Intracellular trafficking of a fiber-modified adenovirus using lipid raft/caveolae endocytosis.

Rogée S, Grellier E, Bernard C, Loyens A, Beauvillain JC, D'halluin JC, Colin M.

Mol Ther. 2007 Nov;15(11):1963-72. Epub 2007 Aug 21.

6.

Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21.

Mailly L, Renaut L, Rogée S, Grellier E, D'Halluin JC, Colin M.

Mol Ther. 2006 Aug;14(2):293-304. Epub 2006 Jun 2.

7.
8.

Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter region.

Cauffiez C, Klinzig F, Rat E, Tournel G, Allorge D, Chevalier D, Lovecchio T, Pottier N, Colombel JF, Lhermitte M, D'Halluin JC, Broly F, Lo-Guidice JM.

Biochem Pharmacol. 2004 Jun 15;67(12):2231-8.

PMID:
15163554
9.

Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.

Renaut L, Colin M, Leite JP, Benko M, D'Halluin JC.

Virology. 2004 Apr 10;321(2):189-204.

12.

Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses.

Avvakumov N, Wheeler R, D'Halluin JC, Mymryk JS.

J Virol. 2002 Aug;76(16):7968-75.

13.

A rapid and easy method for production and selection of recombinant adenovirus genomes.

Renaut L, Bernard C, D'Halluin JC.

J Virol Methods. 2002 Feb;100(1-2):121-31.

PMID:
11742659
14.

Characterization of new mutations in the coding sequence and 5'-untranslated region of the human prostacylcin synthase gene (CYP8A1).

Chevalier D, Cauffiez C, Bernard C, Lo-Guidice JM, Allorge D, Fazio F, Ferrari N, Libersa C, Lhermitte M, D'Halluin JC, Broly F.

Hum Genet. 2001 Feb;108(2):148-55.

PMID:
11281454
15.

c-Myb protein binds to the EP element of the HBV enhancer and regulates transcription in synergy with NF-M.

David-Cordonnier MH, Hamdane M, D'Halluin JC.

Biochim Biophys Acta. 1999 Jul 7;1446(1-2):82-92.

PMID:
10395921
16.

Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter.

Spire-Vayron de la Moureyre C, Debuysère H, Fazio F, Sergent E, Bernard C, Sabbagh N, Marez D, Lo Guidice JM, D'halluin JC, Broly F.

Pharmacogenetics. 1999 Apr;9(2):189-98.

PMID:
10376766
17.

The DNA-binding domain of human c-Abl tyrosine kinase promotes the interaction of a HMG chromosomal protein with DNA.

David-Cordonnier MH, Payet D, D'Halluin JC, Waring MJ, Travers AA, Bailly C.

Nucleic Acids Res. 1999 Jun 1;27(11):2265-70.

18.
19.

Determination of the human c-Abl consensus DNA binding site.

David-Cordonnier MH, Hamdane M, Bailly C, D'Halluin JC.

FEBS Lett. 1998 Mar 13;424(3):177-82.

20.

Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).

Hamdane M, David-Cordonnier MH, D'Halluin JC.

Oncogene. 1997 Nov 6;15(19):2267-75.

22.
23.

Virus assembly.

D'Halluin JC.

Curr Top Microbiol Immunol. 1995;199 ( Pt 1):47-66. Review. No abstract available.

PMID:
7555060
24.

Comparison between E1A gene from oncogenic and non-oncogenic adenoviruses in cellular transformation (Ad E1A conserved region).

Leclére V, Huvent I, Verwaerde P, Cousin C, D'Halluin JC.

Arch Virol. 1993;132(3-4):343-57.

PMID:
8379854
25.

Adenovirus capsid proteins interact with HSP70 proteins after penetration in human or rodent cells.

Niewiarowska J, D'Halluin JC, Belin MT.

Exp Cell Res. 1992 Aug;201(2):408-16.

PMID:
1639138
27.

Regulation of the biosynthesis of subgroup C adenovirus protein IVa2.

Winter N, D'Halluin JC.

J Virol. 1991 Oct;65(10):5250-9.

28.

Cellular transformation by E1 genes of enteric adenoviruses.

Cousin C, Winter N, Gomes SA, D'Halluin JC.

Virology. 1991 Mar;181(1):277-87.

PMID:
1825253
29.

Nucleotide sequence and regulation of the adenovirus type 3 E2A early promoter.

Heysen A, Verwaerde P, D'Halluin JC.

Virology. 1991 Mar;181(1):241-50.

PMID:
1825252
30.

Adenovirus transformed monkey cell lines permissive to enteric adenovirus type 40.

Nascimento JP, Leite JP, Winter N, D'Halluin JC.

J Virol Methods. 1990 Jun;28(3):321-5.

PMID:
2143509
32.

Negative effect of a cis-acting pBR322 element on adenovirus E1a gene expression.

Leite JP, Cousin C, Heysen A, D'Halluin JC.

Gene. 1989 Oct 30;82(2):351-6.

PMID:
2531108
33.
34.
35.

Expression of protein IIIa of human adenovirus type 2 in Escherichia coli.

Cuillel M, Milleville M, D'Halluin JC.

Gene. 1987;55(2-3):295-301.

PMID:
3311886
36.
38.

An adenovirus cytocidal function related to the control of a cellular pH 4 endonuclease activity.

D'Halluin JC, Delsert C, Milleville M, Boulanger P.

J Gen Virol. 1985 Sep;66 ( Pt 9):1873-87.

PMID:
2993479
39.
40.

Characterization of an early temperature-sensitive and cytocidal double mutant of adenovirus type 2.

D'Halluin JC, Cousin C, Niel C, Boulanger P.

J Gen Virol. 1984 Aug;65 ( Pt 8):1305-17.

PMID:
6540295
41.

Initiation rate of adenovirus DNA synthesis in infected cell.

D'Halluin JC, Milleville M.

Biochim Biophys Acta. 1984 May 15;782(1):67-75.

PMID:
6426519
43.

Restriction maps of human adenovirus types 2, 5 and 3 for BclI, ClaI, pvul and SphI endonucleases.

D'Halluin JC, Milleville M, Boulanger PA.

Gene. 1983 Jan-Feb;21(1-2):165-9.

PMID:
6301946
45.

Effects of novobiocin on adenovirus DNA synthesis and encapsidation.

D'Halluin JC, Milleville M, Boulanger P.

Nucleic Acids Res. 1980 Apr 11;8(7):1625-41.

46.

Human adenovirus type 2 protein IIIa. II. Maturation and encapsidation.

Boudin ML, D'Halluin JC, Cousin C, Boulanger P.

Virology. 1980 Feb;101(1):144-56. No abstract available.

PMID:
7355575
47.
48.

Adenovirus early function required for protection of viral and cellular DNA.

D'Halluin JC, Allart C, Cousin C, Boulanger PA, Martin GR.

J Virol. 1979 Oct;32(1):61-71.

49.

Isolation and characterization of adenovirus type 2 vertex capsomer (penton base).

Boudin ML, Moncany M, D'Halluin JC, Boulanger PA.

Virology. 1979 Jan 15;92(1):125-38. No abstract available.

PMID:
419686
50.

Isolation and phenotypic characterization of human adenovirus type 2 temperature-sensitive mutants.

Martin GR, Warocquier R, Cousin C, D'Halluin JC, Boulanger PA.

J Gen Virol. 1978 Nov;41(2):303-14.

PMID:
722282

Supplemental Content

Loading ...
Support Center